Today's Information

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2022/08/02 Time of announcement 16:25:37
Subject 
 To clarify report of China Times, Commercial Times
and Economic Daily News on Aug 02, 2022
Date of events 2022/08/02 To which item it meets paragraph 53
Statement 
1.Date of occurrence of the event:2022/08/02
2.Company name:TTY Biopharm Company Limited
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):Head Office
4.Reciprocal shareholding ratios:N/A
5.Name of the reporting media:
China Times on Aug 02, 2022 edition A05
Commercial Times on Aug 02, 2022 edition B06
Economic Daily News on Aug 02, 2022 edition C04
6.Content of the report:
Title of China Times, "Ms. Hou, Ching-Lan proposed 3 major strategies with
seeking for doubling revenue within future 5 years."
Content of China Times,
The first paragraph, "With rich experiences on international pharmaceutical
marketing and business management, Ms. Hou, Ching-Lan, assuming the position
of General Manager for TTY Biopharm for 3 months, has formulated a
comprehensive and specific plan toward internationalization.
Ms. Hou, Ching-Lan mentioned that TTY Biopharm aims on doubling revenue
within future 5 years through launching new products, expanding domestic and
international markets, and providing research, development and manufacturing
services."

Title of Commercial Times, "TTY Biopharm seeks for doubling revenue in future
5 years. Ms. Hou, Ching-Lan, General Manager of TTY Biopharm, develops 3
major strategies aim on replicating successful experiences in Taiwan and
entering Southeast Asian markets."
Content of Commercial Times,
The first paragraph, "Ms. Hou, Ching-Lan, the new General Manager of TTY
Biopharm (4105: Taiwan), on Aug 1st said that TTY Biopharm will implement 3
strategies- launching new products, expanding domestic and international
markets, and providing research, development and manufacturing services, for
the purpose of replicating successful experiences in Taiwan and entering
Southeast Asian markets. TTY Biopharm aims on doubling revenue in future 5
years; meanwhile, the institutional investors said that TTY Biopharm has
potential to reach revenue of NT 10 billion."

Title of Economic Daily News, "TTY Biopharm seeks for revenue growth with
3 major strategies."
Content of Economic Daily News,
The first paragraph, "Ms. Hou, Ching-Lan, the new General Manager of TTY
Biopharm (4105: Taiwan), presented the business outlook on the media
conference on Aug 1st. Ms. Hou, Ching-Lan mentioned that TTY Biopharm will
implement 3 major strategies- launching new products, expanding domestic and
international markets, and providing research, development and manufacturing
services for the purpose of doubling revenue within future 5 years."
7.Cause of occurrence:
(1)Regarding the description of "revenue doubles within 5 years", it is the
business goal of the Company, not predicted financials announced by
the Company.
(2)Regarding the description of "revenue potentially could reach NT 10
billion within 5 years", it is purely estimated by institutional investors,
not predicted financials announced by the Company.
8.Countermeasures:
To do clarification via announcement of material information.
9.Any other matters that need to be specified:
The company has no financial forecast. Practical operating result and
practical sales and profitability, the company announces on regular basis
in MOPS as reference to investors.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

TTY Biopharm Co. Ltd. published this content on 02 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 August 2022 08:39:04 UTC.